Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Bosco who wrote (754)	3/10/2000 6:02:00 PM
From: david james	Respond to of 1298

PE Biosystems Replaces Genentech as One of Eleven Presenting Companies at Bay Area Biotechnology Stocks Forum March 11 Roche Offering of Genentech Shares Triggers 'Quiet Period' SANTA CLARA, Calif., Mar 10, 2000 /PRNewswire via COMTEX/ -- PE Biosystems (NYSE: PEB) will replace Genentech (NYSE: DNA) as a presenting company at the Eighth Informed Investors Biotechnology Stocks Forum Saturday, March 11 at the Westin Hotel in Santa Clara. Genentech had been scheduled to appear, but yesterday Roche Holding of Switzerland, Genentech's majority owner, announced that it intended to sell off 19 million Genentech shares, reducing its stake in the company to 58% from 66%. Roche's plans, announced in an S-3 filing with the Securities and Exchange Commission, put Genentech into a "quiet period" during which time the company is forbidden from speaking publicly to investors. Consequently, the company said it would be unable to appear as scheduled at Saturday's biotechnology conference. PE BioSystems is headquartered in Foster City, CA, not far from Genentech's home office in South San Francisco. PE Biosystems Group consists of four business units and a shared service organization: PE Biosystems Group are Applied Biosystems, PerSeptive Biosystems, PE Informatics, and Tropix. PE BioSystem's sister company under the PE Corp. umbrella is Celera Genomics. The other presenting companies are: Cell Genesys, Cell Therapeutics, Connetics, Biomira, Depomed, ICN Pharmaceuticals, Magainin Pharmaceuticals, Photogen Technologies, SangStat and Targeted Genetics. Attendance is $25 prepaid, $40 at the door. To register, go to www.informedinvestors.com or call 800-992-4683. Investors unable to attend in person can order an audio tape set of the presentations or listen to the sessions live or archived over the Internet. Check Informed Investors' Web site for details. Keynote speakers are Jim McCamant, publisher of the Medical Technology Stock Letter, and Chris Winter, Ph.D. of Stanford University's Biological Sciences Department. InformedInvestors.com is the leading producer of online and offline industry-specific investment conferences for individual investors and offers a growing stable of resources for in-depth sector-analysis, including the weekly biotech-sector radio show, "BioTalk."